More:    MJNA HOME        CANNABIS NEWS        SHOP        CONTACT 

  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Follow
  • Dashboard
  • Reports & Disclosure
  • Financial Results
  • Shareholder
    • Shareholder Information
    • Shareholder Rewards
  • News
    • Media Coverage
    • Press Releases
Medical Marijuana, Inc. Announces Its Cannabis Drug Research and Drug Development Pipeline Update

Medical Marijuana, Inc. Announces Its Cannabis Drug Research and Drug Development Pipeline Update

by adminAdrianRamirez | Apr 20, 2016 | Axim Biotechnologies, Company News, Kannalife Sciences, Press Releases

MJNA’s Investments Support Development of New Cannabis-Based Medications and Delivery Methods; Developments Further the Reintroduction of Cannabis Medications Globally SAN DIEGO, CA — April 20, 2016 — Medical Marijuana, Inc. (OTC: MJNA) is pleased to announce...
AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in Interview

AXIM Biotechnologies Lays Out Powerhouse IP Pipeline, Cannabinoid R&D in Interview

by adminAdrianRamirez | Feb 26, 2016 | Axim Biotechnologies, Company News, Press Releases

AXIM® Biotech Discusses Patented Cannabinoid-Release Chewing Gum – MedChew RX™; Future Patent-Pending Products Including: Oral Care, Skin Care, Suppository, and Ocular Treatments SAN DIEGO, Feb. 25, 2016 (GLOBE NEWSWIRE) — Medical Marijuana, Inc. (OTC Pink:MJNA) is...
Reuters Features Medical Marijuana Inc. Portfolio Company AXIM Biotechnologies, Talks Discounted Cannabis Source and Its Impact on CBD Chewing Gum

Reuters Features Medical Marijuana Inc. Portfolio Company AXIM Biotechnologies, Talks Discounted Cannabis Source and Its Impact on CBD Chewing Gum

by adminAdrianRamirez | Jan 6, 2016 | Axim Biotechnologies, Company News, Media Coverage

Big news today for Medical Marijuana Inc. portfolio company AXIM Biotechnologies, literally. They were featured in an article on Reuters by Natalie Grover, who reported that the cannabis biotechnology company “has a trump card in its quest to develop a...
Medical Marijuana Inc. Portfolio Company AXIM Biotech Featured By Reuters For Patented Cannabinoid Chewing Gum

Medical Marijuana Inc. Portfolio Company AXIM Biotech Featured By Reuters For Patented Cannabinoid Chewing Gum

by adminAdrianRamirez | Jan 6, 2016 | Axim Biotechnologies, Company News, Press Releases

MEDICAL MARIJUANA, INC. INVESTMENT – AXIM BIOTECH – FEATURED BY REUTERS; CANNABIS “GUM TO TREAT MULTIPLE SCLEROSIS” PAIN AND SPASTICITY AXIM® Biotech’s Clinical Trials on MedChew Rx™ Patented Cannabinoid Release Chewing Gum Provides New Medicine Delivery Method for...
Axim Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

Axim Biotechnologies Secures Land Down Payment For Hemp Life Sciences Manufacturing Site

by adminAdrianRamirez | Oct 30, 2015 | Axim Biotechnologies, Company News, Press Releases

Company’s Global Manufacturing Facility Move Forward in Almere, The Netherlands New York – October 30, 2014 – AXIM Biotechnologies, Inc. (OTC: AXIM) is proud to announce that it has secured the down payment on land to build the Company’s manufacturing...
« Older Entries
Next Entries »

Recent Posts

  • Medical Marijuana, Inc. Appoints New CEO; Highlights Renewed Focus on Profitability, Further Expansion
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Launches Two New Full Spectrum Concentrations in Brazil With Competitive Price Point
  • Medical Marijuana, Inc. Subsidiary Kannaway Expands Leadership Team With Appointment of Industry Veterans to Roles of Executive Vice President and Vice President of Information Technology
  • Medical Marijuana, Inc. Subsidiary HempMeds® Brasil Celebrates Major Features Across Several Marquee Brazilian Press Outlets
  • Medical Marijuana, Inc. Subsidiary HempMeds® Mexico Participates in Research Finding Promising Therapeutic Benefits of CBD in Parkinson’s Disease Treatment

Recent Comments

No comments to show.

Home     Company    Education     Careers     Shop

This article may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties.

Food and Drug Administration (FDA) Disclosure

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.

Leaving Our Website Disclaimer: If we have a research link to a website where we sell products or have product information you are now leaving the medicalmarijuanainc.com website. Links to any informational websites are provided solely as a service to our users.

The link provides additional information that may be useful or interesting and has no aliation to the promotion, sale and distribution of Medical Marijuana Inc. products. The link does not constitute an endorsement of these organizations by Medical Marijuana Inc. and none should be inferred. Please view our full Terms Of Use Agreement for more information and the terms and conditions governing your use of this site.

* Cannabidiol (CBD) is a naturally-occurring constituent of the industrial hemp plant.

Medical Marijuana Inc. does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US.CSA). The company does grow, sell and distribute hemp based products.

© 2021 Medical Marijuana, Inc. All Rights Reserved.